Literature DB >> 23436479

Utilizing NMR and EPR spectroscopy to probe the role of copper in prion diseases.

Abdul-Hamid M Emwas1, Zeyad A Al-Talla, Xianrong Guo, Suliman Al-Ghamdi, Harbi T Al-Masri.   

Abstract

Copper is an essential nutrient for the normal development of the brain and nervous system, although the hallmark of several neurological diseases is a change in copper concentrations in the brain and central nervous system. Prion protein (PrP) is a copper-binding, cell-surface glycoprotein that exists in two alternatively folded conformations: a normal isoform (PrP(C)) and a disease-associated isoform (PrP(Sc)). Prion diseases are a group of lethal neurodegenerative disorders that develop as a result of conformational conversion of PrP(C) into PrP(Sc). The pathogenic mechanism that triggers this conformational transformation with the subsequent development of prion diseases remains unclear. It has, however, been shown repeatedly that copper plays a significant functional role in the conformational conversion of prion proteins. In this review, we focus on current research that seeks to clarify the conformational changes associated with prion diseases and the role of copper in this mechanism, with emphasis on the latest applications of NMR and EPR spectroscopy to probe the interactions of copper with prion proteins.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436479     DOI: 10.1002/mrc.3936

Source DB:  PubMed          Journal:  Magn Reson Chem        ISSN: 0749-1581            Impact factor:   2.447


  7 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

2.  Untargeted Metabolomic Profiling and Antioxidant Capacities of Different Solvent Crude Extracts of Ephedra foeminea.

Authors:  Ruba Al-Nemi; Arwa A Makki; Khaled Sawalha; Dina Hajjar; Mariusz Jaremko
Journal:  Metabolites       Date:  2022-05-17

3.  The tachykinin peptide neurokinin B binds copper forming an unusual [CuII(NKB)2] complex and inhibits copper uptake into 1321N1 astrocytoma cells.

Authors:  Debora Russino; Elle McDonald; Leila Hejazi; Graeme R Hanson; Christopher E Jones
Journal:  ACS Chem Neurosci       Date:  2013-08-07       Impact factor: 4.418

4.  Copper-induced structural propensities of the amyloidogenic region of human prion protein.

Authors:  Caterina Migliorini; Adalgisa Sinicropi; Henryk Kozlowski; Marek Luczkowski; Daniela Valensin
Journal:  J Biol Inorg Chem       Date:  2014-04-16       Impact factor: 3.358

Review 5.  Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review.

Authors:  Abdul-Hamid Emwas; Claudio Luchinat; Paola Turano; Leonardo Tenori; Raja Roy; Reza M Salek; Danielle Ryan; Jasmeen S Merzaban; Rima Kaddurah-Daouk; Ana Carolina Zeri; G A Nagana Gowda; Daniel Raftery; Yulan Wang; Lorraine Brennan; David S Wishart
Journal:  Metabolomics       Date:  2014-11-21       Impact factor: 4.290

Review 6.  "What Doesn't Kill You Makes You Stronger": Future Applications of Amyloid Aggregates in Biomedicine.

Authors:  Sherin Abdelrahman; Mawadda Alghrably; Joanna Izabela Lachowicz; Abdul-Hamid Emwas; Charlotte A E Hauser; Mariusz Jaremko
Journal:  Molecules       Date:  2020-11-11       Impact factor: 4.411

Review 7.  Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations.

Authors:  Benjamin Gabriel Poulson; Kacper Szczepski; Joanna Izabela Lachowicz; Lukasz Jaremko; Abdul-Hamid Emwas; Mariusz Jaremko
Journal:  RSC Adv       Date:  2019-12-24       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.